The page is the record's research on the issuer — no analyst, no rating, no view. # PROKIDNEY CORP. (NASDAQ: PROK) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is PROKIDNEY CORP., listed on NASDAQ under ticker PROK, with ISIN US74291D1046. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-E9). The security type is Corporate, the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is Cayman Islands. The issuer is listed, not halted. ## The disclosure read The record holds 45 filings in the twelve months to 2026-11-08, across 24 filing days. The median gap between filing days is 12 days. The latest filing is dated 2026-11-03, five days before the record date, and is of type directors_dealings. The exchange median cadence gap is 6.0 days across 4,359 NASDAQ issuers, with a median of 52 filings and a median latency of 5.0 days. The sector median cadence gap is 5.5 days across 176 issuers in 2836 Biological Products, (No Diagnostic Substances), with a median of 65.5 filings and a median latency of 4.0 days. The window holds 20 directors_dealings, 10 regulatory_filing, 8 results, 3 agm_egm, 3 corporate_news and 1 prospectus. ## Auditor The auditor of record is Ernst & Young LLP, located in Atlanta, Georgia, United States. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change entries. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client_categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001850270.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/PROK (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1850270/000119312526113881/prok-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/PROK (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/PROK · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp